Grundinformationen
- Standard-SMILES
CC(C)(Oc1ccc(Cl)cc1)C(=O)O- InChIKey
TXCGAZHTZHNUAI-UHFFFAOYSA-N- Summenformel
- C10H11ClO3
- Durchschnittliche Molmasse
- 214,64 g/mol
- Monoisotopische Masse
- 214,03967189
Überblick
Clofibric acid is a monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate. It has a role as a herbicide, an antineoplastic agent, an antilipemic drug, an anticholesteremic drug, a PPARalpha agonist and a marine xenobiotic metabolite. It is a monocarboxylic acid, an aromatic ether and a member of monochlorobenzenes. It is functionally related to an isobutyric acid.
Namen und Bezeichner
- Bevorzugter Name
- Clofibric Acid
- IUPAC
- 2-(4-chlorophenoxy)-2-methylpropanoic acid
- Lokaler Name
- 2-(p-Chlorphenoxy)-2-methylpropionsure
- Englischer Name
- 2-(4-Chlorophenoxy)-2-methylpropionic acid
- Summenformel
- C10H11ClO3
- Molmasse
- 214.65
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
882-09-7- PubChem CID
- 2797
- DTXSID
DTXSID1040661- ChEMBL
CHEMBL683- ChEBI
CHEBI:34648- UNII
- 53PF01Q249
- EC Number
- 212-925-9
- Nikkaji
- J7.154D
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,6
- Polarare Oberfläche (TPSA)
- 46,5 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 3
- Schwere Atome
- 14
- Formalladung
- 0
- Komplexität
- 207
Experimentelle und physikochemische Eigenschaften
Ionization Efficiency
Positive
-0.44
2.7
Agilent XCT
Electrospray ionization
formic acid (5.3nM)
Collision Cross Section
146.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
149.4 Ų [M-H]-
Physikochemische Eigenschaften
- Schmelzpunkt
- 120 · 120-122 °C(lit.)
- Siedepunkt
- 308.11 °C · 308.11°C (rough estimate)
- Dichte
- 1.2413 · 1.2413 (rough estimate)
- Brechungsindex
- 1.522 · 1.5220 (estimate)
- storage temp.
- Sealed in dry,Room Temperature
- Löslichkeit
- Chloroform, Methanol
- Aggregatzustand
- Crystals or Crystalline Powder
- pka
- 3.18 · 3.18±0.10(Predicted)
- Farbe
- Pale yellow to brownish
- Merck
- 14 · 14,2378
- BRN
- 1874067 · 1874067
- InChI
- 1S/C10H11ClO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,1-2H3,(H,12,13)
- InChIKey
- TXCGAZHTZHNUAI-UHFFFAOYSA-N
- SMILES
- CC(C)(Oc1ccc(Cl)cc1)C(O)=O
- CAS Datenbank
- 882 · 882-09-7(CAS DataBase Reference)
- NIST chemische Informationen
- Clofibric acid(882-09-7)
- EPA chemische Informationen
- 2 · Propanoic acid, 2-(4-chlorophenoxy)-2-methyl- (882-09-7)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 47 reports by companies from 4 notifications to the ECHA C&L Inventory.
Gefahrenhinweise
Sicherheitsdaten
- wgk
- 3
- hs_code
- 29189900
- RTECS-Nr.
- UE9455000
- risk_code
- 22-20/21/22
- hazard_code
- Xn,Xi
- safety_code
- 36-24/25
- hazard_class
- IRRITANT
- Speicherklasse
- 11 - Combustible Solids
- Hazard Classifications
- Acute Tox. 4 Oral
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Substances used to lower plasma CHOLESTEROL levels.
Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.
Anwendungen
BeschreibungClofibric acid is a peroxisome proliferator-activated receptor α (PPARα) agonist (EC50 = 50 μM in a transactivation assay) and the active metabolite of clofibrate . It is formed from clofibrate by tissue and serum esterases. Dietary administration of clofibric acid (0.067-0.22%) reduces serum cholesterol, phospholipid, and triglyceride levels in rats. It decreases glutamate oxaloacetate transaminase (GOT) levels and increases glutamate pyruvate transaminase (GPT) and lactate dehydrogenase (LDH) levels, markers of xenobiotic stress, in the plasma of carp (C. carpio) when administered in tank water at a concentration of 10 μg/L. Clofibric acid has been found in wastewater effluent.
VerwendenAntilipemic.
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter50 Anbieter
Ergänzende Hinweise
DefinitionChEBI: A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…